Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,702,599 papers from all fields of science
Search
Sign In
Create Free Account
Precursor Cell Lymphoblastic Leukemia Lymphoma
Known as:
ALL
, Acute Lymphoid Leukemia
, Leukemia, Acute Lymphocytic
Expand
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
27 relations
10 ML Idarubicin Hydrochloride 1 MG/ML Injection
ASPARAGINASE
Acute lymphocytic leukemia
Aggressive natural killer-cell leukemia
Expand
Narrower (1)
Acute lymphoblastic leukemia with lymphomatous features
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Tisagenlecleucel in Children and Young Adults with B‐Cell Lymphoblastic Leukemia
S. Maude
,
T. Laetsch
,
+32 authors
S. Grupp
The New England journal of medicine
2018
Corpus ID: 205102531
Background In a single‐center phase 1–2a study, the anti‐CD19 chimeric antigen receptor (CAR) T‐cell therapy tisagenlecleucel…
Expand
Highly Cited
2015
Highly Cited
2015
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee
,
J. Kochenderfer
,
+16 authors
C. Mackall
The Lancet
2015
Corpus ID: 6359940
Highly Cited
2014
Highly Cited
2014
Chimeric antigen receptor T cells for sustained remissions in leukemia.
S. Maude
,
N. Frey
,
+16 authors
S. Grupp
The New England journal of medicine
2014
Corpus ID: 8474298
BACKGROUND Relapsed acute lymphoblastic leukemia (ALL) is difficult to treat despite the availability of aggressive therapies…
Expand
Highly Cited
2013
Highly Cited
2013
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
S. Grupp
,
M. Kalos
,
+10 authors
C. June
The New England journal of medicine
2013
Corpus ID: 5132358
Chimeric antigen receptor-modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic…
Expand
Review
2009
Review
2009
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
J. Vardiman
,
J. Thiele
,
+8 authors
C. Bloomfield
Blood
2009
Corpus ID: 3101472
Recently the World Health Organization (WHO), in collaboration with the European Association for Haematopathology and the Society…
Expand
Review
2009
Review
2009
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Raphael Kopan
,
M. Ilagan
Cell
2009
Corpus ID: 6141139
Highly Cited
2004
Highly Cited
2004
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
A. Weng
,
A. Ferrando
,
+6 authors
J. Aster
Science
2004
Corpus ID: 24049536
Very rare cases of human T cell acute lymphoblastic leukemia (T-ALL) harbor chromosomal translocations that involve NOTCH1, a…
Expand
Highly Cited
2001
Highly Cited
2001
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
B. Druker
,
C. Sawyers
,
+5 authors
M. Talpaz
The New England journal of medicine
2001
Corpus ID: 26116914
BACKGROUND BCR-ABL, a constitutively activated tyrosine kinase, is the product of the Philadelphia chromosome. This enzyme is…
Expand
Highly Cited
1999
Highly Cited
1999
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.
T. Golub
,
D. Slonim
,
+9 authors
E. Lander
Science
1999
Corpus ID: 2914506
Although cancer classification has improved over the past 30 years, there has been no general approach for identifying new cancer…
Expand
Highly Cited
1990
Highly Cited
1990
Graft-versus-leukemia reactions after bone marrow transplantation.
M. Horowitz
,
R. Gale
,
+7 authors
B. Speck
Blood
1990
Corpus ID: 16868697
To determine whether graft-versus-leukemia (GVL) reactions are important in preventing leukemia recurrence after bone marrow…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE